← Leaderboards
Jerry A Nick
Seattle Children'S Hospital
$4,265,868
Attributed
$6,632,894
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,323,092 · 4
FDA$2,309,802 · 1
By mechanism
R01$5,653,962 · 3
P01$755,696 · 1
K08$223,236 · 1
Top collaborators
- Jane Hill4 shared
- Christopher Hooper Goss3 shared
- Pradeep Singh3 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Kevin Urdahl$86,597,961
- Rafael E Hernandez$1,366,368
- Stephanie Duggins Davis$6,278,112
- Rhea Coler$35,184,139
- Christoph Grundner$14,681,687
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingGenesBacteriaPathogenesisResponseInfectionSignal TransductionNeutrophilNational Heart, Lung, And Blood InstituteGene ExpressionPhenotypeImmunityImpairmentImmune SystemGene FamilyImmune ResponseInflammatoryBacterial InfectionsChemotaxisEvoked PotentialsChronicClinically RelevantExposure ToChemokine
Grant awards (18)
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).$739,415
R01 · FY2025 · FD
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).$716,405
R01 · FY2023 · FD
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2022 · HL · contact PI
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2021 · HL · contact PI
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).$853,982
R01 · FY2020 · FD
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$410,000
R01 · FY2020 · HL · contact PI
Prospective Longitudinal Assessment of Culture-Independent Molecular Airway Markers of Nontuberculous Mycobacteria$424,316
R01 · FY2019 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$342,856
R01 · FY2010 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$342,876
R01 · FY2009 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$283,204
R01 · FY2009 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$14,102
R01 · FY2009 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$342,895
R01 · FY2008 · HL · contact PI
Viral-induced Adaptation of Neutrophil Response in ARDS$363,911
R01 · FY2007 · HL · contact PI
Regulation of Neutrophil Responses by p38 MAP Kinase in Acute Lung Injury$266,128
P01 · FY2006 · HL · contact PI
Regulation of Neutrophil Responses by p38 MAP Kinase in Acute Lung Injury$252,187
P01 · FY2005 · HL
Regulation of Neutrophil Responses by p38 MAP Kinase in Acute Lung Injury$237,381
P01 · FY2002 · HL
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS$111,618
K08 · FY2001 · HL
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS$111,618
K08 · FY2000 · HL